ArticleMedComm2024

Statins, but not proprotein convertase subtilisin-kexin type 9 inhibitors, lower chemerin in hypercholesterolemia via low-density lipoprotein receptor upregulation.

Lunbo Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.